Granite Investment Partners, LLC - IMPRIMIS PHARMACEUTICALS INC ownership

IMPRIMIS PHARMACEUTICALS INC's ticker is IMMY and the CUSIP is 45323A201. A total of 15 filers reported holding IMPRIMIS PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Granite Investment Partners, LLC ownership history of IMPRIMIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2018$175,000
-74.5%
30,838
-87.5%
0.01%
-67.5%
Q3 2018$687,000
+82.7%
247,117
+44.5%
0.04%
+66.7%
Q2 2018$376,000
+216.0%
170,962
+153.8%
0.02%
+200.0%
Q1 2018$119,000
-62.3%
67,355
-63.8%
0.01%
-60.0%
Q4 2017$316,000
+54.1%
186,214
+46.4%
0.02%
+53.8%
Q3 2017$205,000
-77.3%
127,214
-55.0%
0.01%
-78.7%
Q2 2017$905,000
-27.0%
282,654
-4.9%
0.06%
-28.2%
Q1 2017$1,239,000
+249.0%
297,297
+109.0%
0.08%
+226.9%
Q4 2016$355,000
-42.1%
142,226
-11.6%
0.03%
-43.5%
Q3 2016$613,000
+5.0%
160,876
+3.7%
0.05%0.0%
Q2 2016$584,000
-3.0%
155,190
+2.4%
0.05%
-16.4%
Q1 2016$602,000
-30.6%
151,510
+21.0%
0.06%
-29.5%
Q4 2015$868,000
-25.2%
125,251
-30.7%
0.08%
-29.7%
Q3 2015$1,160,000
+10.1%
180,768
+39.5%
0.11%
+14.4%
Q2 2015$1,054,000
-18.8%
129,627
-20.2%
0.10%
-13.4%
Q1 2015$1,298,000
+43.3%
162,490
+34.5%
0.11%
+9.8%
Q4 2014$906,000
+147.5%
120,791
+144.9%
0.10%
+104.0%
Q3 2014$366,000
+83.9%
49,320
+72.2%
0.05%
+78.6%
Q2 2014$199,00028,6490.03%
Other shareholders
IMPRIMIS PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,722,000$9,798,0003.66%
Diametric Capital, LP 252,160$1,453,0001.12%
Birchview Capital, LP 180,000$1,024,0000.97%
EAM Global Investors LLC 206,445$1,175,0000.64%
EAM Investors, LLC 301,415$1,715,0000.47%
BARD ASSOCIATES INC 51,550$293,0000.17%
INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC 85,569$487,0000.11%
ARDSLEY ADVISORY PARTNERS LP 75,000$427,0000.11%
PRELUDE CAPITAL MANAGEMENT, LLC 112,859$642,0000.04%
ELLINGTON MANAGEMENT GROUP LLC 16,500$94,0000.03%
View complete list of IMPRIMIS PHARMACEUTICALS INC shareholders